Changchuan Jiang, MD, MPH, Roswell Park Comprehensive Cancer Center, Buffalo, NY, explains the importance of obtaining real-world data when evaluating therapeutic strategies. The gold standard in treatment comparison is the clinical trial. However, in this format, several important demographics are excluded, such as the elderly or patients with underlying comorbidities. This interview took place at the American Association for Cancer Research Annual Meeting in New Orleans, LA.